Track Orchard Therapeutics plc's total assets ($200M) with charts, peers, and YoY trends.
Get informed when a big investor buys or sells
+ FollowLatest change versus the prior comparable period (same company).
Orchard Therapeutics plc (ORTX) currently reports a total assets of $200M as of September 2023. That compares with $230M in the prior-year period — down 13.6% year over year. Use the charts on this page to explore Orchard Therapeutics plc's total assets history and peer comparisons.
Orchard Therapeutics plc's total assets decreased from $230M to $200M — a 13.6% year-over-year decrease (period ending September 2023). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.
Orchard Therapeutics plc reported $200M in total assets as of September 2023. That compares with $230M in the prior-year period — down 13.6% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.
Start with the current total assets of $200M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Orchard Therapeutics plc, and consider following ORTX for alerts when major investors trade the stock.
Orchard Therapeutics plc is classified in the Healthcare sector. On total assets, it currently shows $200M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing ORTX with unrelated industries.